YoungSolvers Webinar: Stumbling Blocks in Drug Design – Applied Medicinal Chemistry

webinar

Mon, 16 Aug 2021, 14:00 CEST (Berlin)

Alexander Neumann

YoungSolvers Webinar: Stumbling Blocks in Drug Design – Applied Medicinal Chemistry

What happens in silico does not have to stay in silico. Although some compounds may appear as very promising drug candidates due to high docking scores or phenomenal affinity predictions, they need subsequent validation to avoid in vivo and in vitrodisenchantment. In this webinar interdisciplinary aspects of medicinal chemistry in computer-aided drug design will be discussed and elucidated. We will adress which molecular scaffolds and functional groups can cause problems during lead-optimization, how to read and digest predicted physicochemical properties, where to search for solutions, as well as many other related topics. A must for every medicinal and computational chemistry enthusiast.

Level: Advanced

Current news

category
Challenge
Winner of Fall 2021 Scientific Challenge: Aaron Kuriakose Prakash with Covalent Tuberculosis Drugs
September 20, 2022 12:56 CEST
We are excited to announce the winner of the Fall 2021 Scientific Challenge: Aaron Kuriakose Prakash from the Madras Christian College (Chennai, India)! In the past twelve months he used the covalent docking feature of SeeSAR to screen for potential drug candidates to treat tuberculosis infections. He got the best...
Read on
category
Software
Introducing eXplore — a New Trillion-Sized Chemical Space by eMolecules
September 12, 2022 13:06 CEST
eXplore – the largest commercial Chemical Space featuring over 2.8 trillion tangible compounds is now available. Created jointly with eMolecules, the Chemical Space was designed to provide users with accessible compounds to match their needs during a drug discovery project. eXplore has been created with a selection of eMolecules’s building...
Read on
category
Events
Recap Drugathon 2022
July 13, 2022 13:10 CEST
The first BioSolveIT Drugathon has concluded and the feedback is overwhelming. Over 400 people from around the globe have registered to this unique drug discovery event where research from around the globe collaborate on a single target structure to design novel compounds. The group of Prof. Anna Hirsch volunteered to...
Read on